Amyloid-targeting Alzheimer's drugs give us hope – but how will they benefit UK patients?
Amyloid-targeting drugs donanemab and lecanemab show promise for slowing the rate of cognitive decline
Stay updated with breaking news from A King Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amyloid-targeting drugs donanemab and lecanemab show promise for slowing the rate of cognitive decline
The Pharmaceutical Journal from the Royal Pharmaceutical Society
The social care costs cap is in the crosshairs as the PM and Chancellor scramble to fill a black hole of up to £60billion in the public finances.
Government plans to bring in 26,000 staff by 2024 to support general practice are behind schedule with just under 12,000 in post so far according to analysis by GPonline - as GPs called for more flexibility to accelerate recruitment.
AT THE start of a new year, many of us start with a determination to have a healthier, happier life.